Skip to content
10-Q

Quarterly Report

AbCellera Biologics Inc. ABCL

0001703057-25-000011

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 298.83M sh
Shares Diluted Q2 2025 · Jun 30, 2025 298.51M sh
Shares Diluted Q2 2025 · Jun 30, 2025 298.11M sh
Shares Diluted Q2 2025 · Jun 30, 2024 294.22M sh
Shares Diluted Q2 2025 · Jun 30, 2024 293.47M sh
Capex Q2 2025 · Jun 30, 2025 $24M
Capex Q2 2025 · Jun 30, 2024 $44.25M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$43.96M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$71.67M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $92.44M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $156.33M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.01B
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.02B
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.06B
Stockholders Equity Q2 2025 · Jun 30, 2024 $1.11B
Stockholders Equity Q2 2025 · Mar 31, 2024 $1.13B
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.15B
Current Liabilities Q2 2025 · Jun 30, 2025 $67.02M
Current Liabilities Q2 2025 · Dec 31, 2024 $76.61M
Total Liabilities Q2 2025 · Jun 30, 2025 $394.99M
Total Liabilities Q2 2025 · Dec 31, 2024 $304.47M
Current Assets Q2 2025 · Jun 30, 2025 $742.15M
Current Assets Q2 2025 · Dec 31, 2024 $751.37M
Total Assets Q2 2025 · Jun 30, 2025 $1.4B
Total Assets Q2 2025 · Dec 31, 2024 $1.36B
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.12
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.27
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.13
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.26
Eps Basic Q2 2025 · Jun 30, 2025 −$0.12
Eps Basic Q2 2025 · Jun 30, 2025 −$0.27
Eps Basic Q2 2025 · Jun 30, 2024 −$0.13
Eps Basic Q2 2025 · Jun 30, 2024 −$0.26
Rd Expense Q2 2025 · Jun 30, 2025 $39.21M
Rd Expense Q2 2025 · Jun 30, 2025 $81.71M
Rd Expense Q2 2025 · Jun 30, 2024 $40.93M
Rd Expense Q2 2025 · Jun 30, 2024 $80.21M
Net Income Q2 2025 · Jun 30, 2025 −$34.73M
Net Income Q2 2025 · Jun 30, 2025 −$80.35M
Net Income Q2 2025 · Mar 31, 2025 −$45.62M
Net Income Q2 2025 · Jun 30, 2024 −$36.93M
Net Income Q2 2025 · Jun 30, 2024 −$77.54M
Net Income Q2 2025 · Mar 31, 2024 −$40.61M
Operating Income Q2 2025 · Jun 30, 2025 −$49.59M
Operating Income Q2 2025 · Jun 30, 2025 −$112.25M
Operating Income Q2 2025 · Jun 30, 2024 −$93.45M
Operating Income Q2 2025 · Jun 30, 2024 −$148.35M
Revenue Q2 2025 · Jun 30, 2025 $17.08M
Revenue Q2 2025 · Jun 30, 2025 $21.32M
Revenue Q2 2025 · Jun 30, 2024 $7.32M
Revenue Q2 2025 · Jun 30, 2024 $17.28M